Skip to main content
. 2021 Jun 13;32(10):1063–1083. doi: 10.1007/s10552-021-01456-8

Table 1.

Sociodemographic and clinical characteristics of early-onset colorectal cancer cases and controls aged 20–49 years, Ontario, Canada, 2018–2019

Characteristics Cases
(n = 175)
Controls
(n = 253)
Age- and sex-adjusted ORb (95% CI)
na
(%)
na
(%)
Age, years
 Mean (SD)

43.1

(5.6)

40.1

(7.9)

N/A
Age group, years
 20–29

6

(3)

36

(14)

N/A
 30–34

11

(6)

18

(7)

 35–39

23

(13)

35

(14)

 40–44

38

(22)

69

(27)

 45–49

97

(55)

95

(38)

Sex
 Male

74

(42)

112

(44)

N/A
 Female

101

(58)

141

(56)

Race/ethnicity
 White

141

(81)

202

(80)

1.00
 East/Southeast Asian

16

(9)

16

(6)

1.50 (0.71–3.15)
 South Asian

5

(3)

16

(6)

0.57 (0.20–1.66)
 Otherc

13

(7)

17

(7)

1.03 (0.48–2.21)
Country of birth
 Canada

146

(83)

184

(73)

1.00
 Outside Canada

29

(17)

69

(27)

0.51 (0.31–0.84)
Highest level of education
 High school graduate or less

32

(18)

46

(19)

1.00
 College or university degree

98

(56)

138

(56)

0.97 (0.57–1.66)
 Post-graduate degree

45

(26)

64

(26)

0.98 (0.54–1.80)
Annual household incomed, CAD$
  < $30,000

9

(5)

23

(10)

1.00
 $30,000–$69,999

29

(18)

44

(20)

1.56 (0.62–3.93)
 $70,000–$100,000

38

(23)

46

(21)

1.91 (0.77–4.70)
  > $100,000

88

(54)

108

(49)

1.85 (0.80–4.29)
 Unknown (prefer not to answer) 11 32
Occupationd
 Professionale

63

(36)

93

(37)

1.00
 Managerial and Administrativef

33

(19)

41

(16)

1.12 (0.63–1.98)
 Sales and Servicesg

25

(14)

34

(13)

1.11 (0.60–2.06)
 Clericalh

22

(13)

21

(8)

1.46 (0.73–2.94)
 Manufacturing, Agriculture, and Tradesi

17

(10)

26

(10)

1.08 (0.53–2.21)
 Student/not employed

7

(4)

27

(11)

0.53 (0.21–1.37)
 Other/unspecified

8

(5)

11

(4)

1.01 (0.38–2.67)
Usual residence during most of life
 Urban

140

(81)

202

(81)

1.00
 Rural

32

(19)

47

(19)

0.98 (0.59–1.63)
Anatomical subsitej
 Proximal colon

41

(24)

N/A N/A
 Distal colon

49

(28)

 Rectum

84

(48)

MSI statusk
 Microsatellite stable or MSI-low

122

(89)

N/A N/A
 MSI-high

15

(11)

 Unknown 38
Stage at diagnosisl
 Stage I

28

(19)

N/A N/A
 Stage II

30

(21)

 Stage III

57

(39)

 Stage IV

31

(21)

 Unknown 29

CAD Canadian Dollar; CI confidence interval; MSI microsatellite instability; N/A not applicable; OR odds ratio; SD standard deviation

aNumbers may not sum up to totals due to missing data. An “unknown” category is shown for variables with > 5% missing data

bAdjusted for age (continuous, years; age at diagnosis for cases and at questionnaire completion for controls) and sex

cIncludes Black (n = 9), Aboriginal (First Nations, Métis, or Inuit; n = 6), and other race/ethnicity (n = 15). Numbers broken down by case/control status are not shown due to small cell sizes

dTwo years ago

eProfessional occupations in natural and applied sciences, health, education, law and social, community and government services

fManagement, business, finance and administration occupations

gSales and service occupations, including occupations related to the hospitality and tourism industries

hAdministrative and office support occupations

iOccupations in manufacturing (e.g., metal, glass, chemicals, wood, pulp, textile), agriculture and natural resources (e.g., farming, fishing, forestry), construction, trades, transport and equipment operation

jBased on International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) topography codes (proximal colon: cecum [C18.0], ascending colon [C18.2], hepatic flexure of colon [C18.3], transverse colon [C18.4], and splenic flexure of colon [C18.5]; distal colon: descending colon [C18.6] and sigmoid colon [C18.7]; rectum: rectosigmoid junction [C19.9] and rectum, not otherwise specified [C20.9])

kBased on immunohistochemistry staining results for DNA mismatch repair proteins (MLH1, MSH2, MSH6, and PMS2). Cases were considered microsatellite stable or MSI-low if they had normal (intact) nuclear staining for all four proteins, else they were considered MSI-high if they had abnormal (deficient) staining for any of the four proteins

lDetermined based on multiple sources of staging information, including pathological staging and clinical staging (pathological stage was given priority where available), in accordance with the American Joint Committee on Cancer (AJCC) tumor-node-metastases (TNM) staging system, 8th Edition